CDKN2A and neoplasm: To further explore how the co‐deletion of IFN‐I influences outcomes in CDKN2A/BHD LUAD, we examined the tumor immune microenvironment by performing an immunity estimation of 25 gene sets associated with innate and adaptive immunity.